CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-30 | Love Douglas PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) | −36,050 | 0 | ||
| 2024-10-15 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Option exercise 10b5-1 | +5,408 | $1.85 | $10K | 76,773 |
| 2024-10-15 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −5,408 | $7.41 | $40K | 71,365 |
| 2024-10-15 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,408 | 30,646 | ||
| 2024-10-01 | Carson William H. Director | Purchase 10b5-1 | +3,200 | $5.97 | $19K | 22,400 |
| 2024-09-19 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −4,500 | $7.10 | $32K | 0 |
| 2024-09-12 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −5,500 | $6.16 | $34K | 4,500 |
| 2024-09-05 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −5,500 | $5.64 | $31K | 10,000 |
| 2024-09-03 | Carson William H. Director | Purchase 10b5-1 | +3,200 | $5.48 | $18K | 19,200 |
| 2024-08-29 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −5,500 | $5.95 | $33K | 15,500 |
| 2024-08-01 | Carson William H. Director | Purchase 10b5-1 | +3,200 | $6.24 | $20K | 16,000 |
| 2024-07-15 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −784 | $6.02 | $5K | 94,622 |
| 2024-07-15 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −1,104 | $6.03 | $7K | 86,468 |
| 2024-07-15 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −1,106 | $6.02 | $7K | 71,365 |
| 2024-07-01 | Carson William H. Director | Purchase 10b5-1 | +3,200 | $5.00 | $16K | 12,800 |
| 2024-06-05 | WIGGANS THOMAS G Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2024-06-05 | Satter Muneer A Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2024-06-05 | Choi Jung Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2024-06-05 | Waddill William D. Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2024-06-05 | Carson William H. Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 |
Page 5 of 15 · 292 trades